| 1 |
matrix metalloproteinase
(10255 times)
|
Neoplasms
(1492 times)
|
TIMP (1030 times)
IL (683 times)
ECM (554 times)
|
1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
|
| 2 |
mitochondrial membrane potential
(2221 times)
|
Biochemistry
(300 times)
|
ROS (1041 times)
NAC (134 times)
LDH (105 times)
|
1992 Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes.
|
| 3 |
mucous membrane pemphigoid
(173 times)
|
Dermatology
(61 times)
|
BP (20 times)
BMZ (16 times)
PV (14 times)
|
1985 Localization of basement membrane components in mucous membrane pemphigoid.
|
| 4 |
monomethyl phthalate
(70 times)
|
Environmental Health
(45 times)
|
MEHP (38 times)
MEP (34 times)
MBzP (26 times)
|
1991 Mutagenicity and metabolism of dimethyl phthalate and its binding to epidermal and hepatic macromolecules.
|
| 5 |
Medical Monitoring Project
(36 times)
|
Acquired Immunodeficiency Syndrome
(16 times)
|
ART (13 times)
HIV (13 times)
MSM (5 times)
|
2007 Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.
|
| 6 |
matched molecular pair
(21 times)
|
Chemistry
(12 times)
|
SAR (5 times)
MMS (2 times)
QSAR (2 times)
|
2010 Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
|
| 7 |
methadone maintenance program
(19 times)
|
Substance-Related Disorders
(6 times)
|
AMP (2 times)
DFP (2 times)
HIV (2 times)
|
1989 [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
|
| 8 |
microsatellite mutator phenotype
(18 times)
|
Neoplasms
(8 times)
|
MMR (3 times)
AP-PCR (2 times)
MSI (2 times)
|
1995 The microsatellite mutator phenotype of colon cancer cells is often recessive.
|
| 9 |
major membrane protein
(14 times)
|
Allergy and Immunology
(5 times)
|
BCG (5 times)
DC (4 times)
HSP (4 times)
|
1990 The major native proteins of the leprosy bacillus.
|
| 10 |
membrane potential
(14 times)
|
Neurology
(4 times)
|
ROS (6 times)
OXPHOS (2 times)
AIF (1 time)
|
1996 Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level.
|
| 11 |
matrix-degrading metalloproteinase
(13 times)
|
Vascular Diseases
(4 times)
|
TIMP (2 times)
UVB (2 times)
VSMC (2 times)
|
1997 Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines.
|
| 12 |
magnetic microparticle
(12 times)
|
Biotechnology
(3 times)
|
BCA (5 times)
BTV (2 times)
GNP (2 times)
|
2006 Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles.
|
| 13 |
masticatory muscle pain
(11 times)
|
Dentistry
(9 times)
|
MPI (2 times)
TMD (2 times)
EPT (1 time)
|
1998 Psychological and physiological parameters of masticatory muscle pain.
|
| 14 |
Mini-Mental Parkinson
(11 times)
|
Neurology
(4 times)
|
MMSE (7 times)
PD (4 times)
ACE-R (2 times)
|
2010 Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
|
| 15 |
methadone maintenance patients
(9 times)
|
Substance-Related Disorders
(8 times)
|
ADHD (1 time)
AHA (1 time)
CalCAP (1 time)
|
1995 Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
|
| 16 |
masticatory myofascial pain
(8 times)
|
Dentistry
(5 times)
|
VAS (4 times)
RDC/TMD (2 times)
AAOP (1 time)
|
1999 Masticatory myofascial pain: an explanatory model integrating clinical, epidemiological and basic science research.
|
| 17 |
mean melting point
(8 times)
|
Endocrinology
(3 times)
|
FA (3 times)
PL (3 times)
DBI (2 times)
|
1991 Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.
|
| 18 |
mitochondrial myopathy
(8 times)
|
Cardiology
(4 times)
|
BMD (4 times)
CI (3 times)
MD (3 times)
|
1996 [Heart muscle involvement in myopathies].
|
| 19 |
modified Mallampati grade
(7 times)
|
Otolaryngology
(7 times)
|
BMI (6 times)
AHI (5 times)
OSA (3 times)
|
1999 Clinical predictors of obstructive sleep apnea.
|
| 20 |
medium molecular peptides
(6 times)
|
Clinical Laboratory Techniques
(2 times)
|
EI (2 times)
AOMP (1 time)
ATFE (1 time)
|
1991 [Blood levels of medium molecular weight peptides and lipid peroxidation activity in the differential diagnosis of diffuse toxic goiter].
|
| 21 |
multichannel matching pursuit
(6 times)
|
Neurology
(3 times)
|
EEG (2 times)
ICA (2 times)
SVM (2 times)
|
2009 Inverse modeling on decomposed electroencephalographic data: a way forward?
|
| 22 |
Multiple Multipole Program
(6 times)
|
Biophysics
(3 times)
|
LSPR (2 times)
AFM (1 time)
FEM (1 time)
|
2004 Induced current density in the foetus of pregnant workers in high magnetic field environments.
|
| 23 |
2-methoxy-4-methylphenol
(5 times)
|
Neoplasms
(3 times)
|
BPO (2 times)
HSG (2 times)
AC (1 time)
|
2004 Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.
|
| 24 |
Marine Mammal Program
(5 times)
|
Veterinary Medicine
(4 times)
|
EBC (1 time)
GGT (1 time)
|
2008 Trace and non-trace elements in blood cells of bottlenose dolphins (Tursiops truncatus): variations with values from liver function indicators.
|
| 25 |
maximal mean power
(5 times)
|
Physiology
(3 times)
|
AT (1 time)
BCM (1 time)
CV (1 time)
|
2005 Power output during women's World Cup road cycle racing.
|
| 26 |
metabolites, monomethyl phthalate
(5 times)
|
Environmental Health
(3 times)
|
MEP (5 times)
mEHP (4 times)
mBP (3 times)
|
2003 Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
|
| 27 |
middle mass peptides
(5 times)
|
Pharmacology
(2 times)
|
---
|
1986 [Role of middle-molecule blood peptides in the development of cardiac depression in thermal burns].
|
| 28 |
minimum miscibility pressure
(5 times)
|
Chemistry Techniques, Analytical
(2 times)
|
MMC (1 time)
MRI (1 time)
PDD (1 time)
|
2003 Determination of gas-oil miscibility conditions by interfacial tension measurements.
|
| 29 |
modified Mallampati
(5 times)
|
Anesthesiology
(4 times)
|
BMI (2 times)
AASI (1 time)
CL (1 time)
|
2006 Craniocervical extension improves the specificity and predictive value of the Mallampati airway evaluation.
|
| 30 |
modulate metalloproteinase
(5 times)
|
Physiology
(2 times)
|
Ang (1 time)
Ang II (1 time)
CTB (1 time)
|
2003 Regulation of trophoblastic gelatinases by proto-oncogenes.
|
| 31 |
multidimensional multiscale parser
(5 times)
|
Medical Informatics
(3 times)
|
HEVC (1 time)
PDS (1 time)
SbS (1 time)
|
2008 Universal image compression using multiscale recurrent patterns with adaptive probability model.
|
| 32 |
membrane mitochondrial potential
(4 times)
|
Physiology
(1 time)
|
ROS (2 times)
A. muricata (1 time)
DS (1 time)
|
2009 Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis.
|
| 33 |
methylmannose polysaccharide
(4 times)
|
Biochemistry
(3 times)
|
AMMP (1 time)
Ea (1 time)
FAs (1 time)
|
1977 Acetylated methylmannose polysaccharide of Streptomyces.
|
| 34 |
mindfulness meditation practice
(4 times)
|
Psychophysiology
(1 time)
|
ANS (1 time)
MBCT (1 time)
MMD (1 time)
|
2015 Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
|
| 35 |
minimum morbidity percentile
(4 times)
|
Environmental Health
(2 times)
|
OHCA (4 times)
RR (1 time)
|
2017 Extreme temperature and out-of-hospital cardiac arrest in Japan: A nationwide, retrospective, observational study.
|
| 36 |
movement-monitoring potentials
(4 times)
|
Brain
(2 times)
|
MP (2 times)
MRCP (2 times)
MRPs (2 times)
|
2004 Perceived effort in force production as reflected in motor-related cortical potentials.
|
| 37 |
malignant mesothelioma of the pleura
(3 times)
|
Medicine
(1 time)
|
Can-Qc (1 time)
|
1985 Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia.
|
| 38 |
maximum mean pressure
(3 times)
|
Orthopedics
(3 times)
|
PP (3 times)
FTI (2 times)
LM (1 time)
|
2005 The effect of terrain on foot pressures during walking.
|
| 39 |
medication management program
(3 times)
|
Health Services Research
(1 time)
|
ED (1 time)
PCMH (1 time)
|
2015 Pharmacist-led medication management program within a patient-centered medical home.
|
| 40 |
metal matrix proteinase
(3 times)
|
Neoplasms
(1 time)
|
AQP3 (1 time)
ECM (1 time)
GSTP1 (1 time)
|
2013 Effect of Chinese herbs on immunoglobulin A nephropathy: a randomized controlled trial.
|
| 41 |
metalloproteinase to tissue inhibitors of metalloproteinase
(3 times)
|
Respiratory Tract Diseases
(1 time)
|
AIA (1 time)
COP (1 time)
OP (1 time)
|
1998 Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
|
| 42 |
Mexican Migration Project
(3 times)
|
Health Services
(1 time)
|
MAFE (1 time)
MEPS (1 time)
PPACA (1 time)
|
2015 Mexican Immigrant Health: Health Insurance Coverage Implications.
|
| 43 |
modified multiple platform
(3 times)
|
Neurology
(2 times)
|
PSD (2 times)
DA (1 time)
FST (1 time)
|
2004 Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery.
|
| 44 |
Montana Meth Project
(3 times)
|
Health Services
(2 times)
|
METH (1 time)
TEDS (1 time)
YRBS (1 time)
|
2008 Drugs, money, and graphic ads: a critical review of the Montana Meth Project.
|
| 45 |
multicellular magnetotactic prokaryote
(3 times)
|
Microbiology
(2 times)
|
DMO (1 time)
|
2007 Magnetic optimization in a multicellular magnetotactic organism.
|
| 46 |
multimuscle pattern
(3 times)
|
Physiology
(3 times)
|
AFL (1 time)
BMI (1 time)
EMGs (1 time)
|
2009 Spherical classification of wavelet transformed EMG intensity patterns.
|
| 47 |
multiple multipole
(3 times)
|
Biomedical Engineering
(1 time)
|
AFM (1 time)
AMS (1 time)
FD (1 time)
|
1993 Multiple multipole method for simulating EM problems involving biological bodies.
|
| 48 |
myristoylated membrane protein
(3 times)
|
Allergy and Immunology
(1 time)
|
LCDV (2 times)
LCDV-PF (2 times)
MCP (2 times)
|
2014 Identification of lymphocystis disease virus from paradise fish Macropodus opercularis (LCDV-PF).
|
| 49 |
1-methoxy-5-methylphenazinium
(2 times)
|
Chemistry Techniques, Analytical
(2 times)
|
MP (1 time)
PCOP (1 time)
|
1999 Uricase-catalyzed oxidation of uric acid using an artificial electron acceptor and fabrication of amperometric uric acid sensors with use of a redox ladder polymer.
|
| 50 |
macrophage metalloelastase
(2 times)
|
Pulmonary Medicine
(1 time)
|
AAD (1 time)
BAL (1 time)
CAS (1 time)
|
2006 Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice.
|
| 51 |
magnetotactic multicellular prokaryote
(2 times)
|
Biophysics
(1 time)
|
---
|
2005 Observation of magnetoreceptive behavior in a multicellular magnetotactic prokaryote in higher than geomagnetic fields.
|
| 52 |
many-celled magnetotactic prokaryote
(2 times)
|
Environmental Health
(1 time)
|
---
|
2007 Flagellar apparatus of south-seeking many-celled magnetotactic prokaryotes.
|
| 53 |
medial midpatellar
(2 times)
|
Rheumatology
(1 time)
|
AL (1 time)
ALJL (1 time)
AM (1 time)
|
2007 Comparison of four different intra-articular injection sites in the knee: a cadaver study.
|
| 54 |
medical marijuana patients
(2 times)
|
Substance-Related Disorders
(2 times)
|
MM (1 time)
NPU (1 time)
|
2017 Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users.
|
| 55 |
medication management pathway
(2 times)
|
Drug-Related Side Effects and Adverse Reactions
(1 time)
|
AF (1 time)
MEs (1 time)
|
2011 A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.
|
| 56 |
medium-weight molecular peptides
(2 times)
|
Therapeutics
(2 times)
|
DTG (1 time)
LPO (1 time)
|
1991 [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
|
| 57 |
metaloproteinase da matriz
(2 times)
|
Jurisprudence
(1 time)
|
Lm (2 times)
MAC (2 times)
CS (1 time)
|
2003 [Immunohistochemical findings in prolonged cerebral hypoxia].
|
| 58 |
metastatic melanoma patients
(2 times)
|
Neoplasms
(1 time)
|
BRAFi (1 time)
CI (1 time)
HR (1 time)
|
2015 The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.
|
| 59 |
metastatic proteins metalloproteinase
(2 times)
|
Biochemistry
(1 time)
|
AGS (1 time)
AST (1 time)
ROS (1 time)
|
2010 Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk.
|
| 60 |
methylmercaptopurine
(2 times)
|
Pharmacology
(2 times)
|
6-MP (1 time)
AZA (1 time)
MP (1 time)
|
2002 Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.
|
| 61 |
micro-magnetic particle
(2 times)
|
Chemistry Techniques, Analytical
(2 times)
|
ABC (3 times)
BBC (2 times)
cyto c (2 times)
|
2013 An aptamer-based bio-barcode assay with isothermal recombinase polymerase amplification for cytochrome-c detection and anti-cancer drug screening.
|
| 62 |
mitochondrial membrane-phospholipid
(2 times)
|
Vascular Diseases
(1 time)
|
CoQ10 (1 time)
DCM (1 time)
omega-3 PUFAs (1 time)
|
1996 Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy.
|
| 63 |
mixed muscle protein
(2 times)
|
Endocrinology
(1 time)
|
MHC (2 times)
GC-C-IRMS (1 time)
SDS-PAGE (1 time)
|
1997 Skeletal muscle myosin heavy chain synthesis in type 1 diabetes.
|
| 64 |
mizoribine 5'-monophosphate
(2 times)
|
Biochemistry
(2 times)
|
IMPDH (2 times)
TAD (1 time)
|
1995 Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
|
| 65 |
mobile measurement platform
(2 times)
|
Environmental Health
(2 times)
|
BC (1 time)
CO (1 time)
EMFAC (1 time)
|
2011 Emission factors for high-emitting vehicles based on on-road measurements of individual vehicle exhaust with a mobile measurement platform.
|
| 66 |
mono-methyl mono-phosphate ester
(2 times)
|
Chemistry
(2 times)
|
NBO (1 time)
NEDA (1 time)
QM/MM (1 time)
|
2007 Interactions between phosphate and water in solution: a natural bond orbital based analysis in a QM/MM framework.
|
| 67 |
mulberry marc purification
(2 times)
|
Nutritional Sciences
(1 time)
|
MJP (1 time)
|
2013 Antioxidant and anti-fatigue effects of anthocyanins of mulberry juice purification (MJP) and mulberry marc purification (MMP) from different varieties mulberry fruit in China.
|
| 68 |
mycophenolate mofetil
(2 times)
|
Ophthalmology
(1 time)
|
HSA (1 time)
MPA (1 time)
|
2012 Mycophenolate mofetil use in the treatment of noninfectious uveitis.
|
| 69 |
myosin/moesin phosphatase
(2 times)
|
Cell Biology
(1 time)
|
Inh2 (1 time)
PP1 (1 time)
|
2000 Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading.
|
| 70 |
peroxynitrite-matrix metalloproteinase
(2 times)
|
Cardiology
(1 time)
|
CAD (1 time)
iNOS (1 time)
LVEF (1 time)
|
2010 Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
|
| 71 |
2-methoxy-2-methyl propanal
(1 time)
|
Biology
(1 time)
|
MMP-acid (1 time)
MMP-OH (1 time)
MTBE (1 time)
|
2009 Advanced oxidation and reduction process chemistry of methyl tert-butyl ether (MTBE) reaction intermediates in aqueous solution: 2-methoxy-2-methyl-propanal, 2-methoxy-2-methyl-propanol, and 2-methoxy-2-methyl-propanoic acid.
|
| 72 |
2-methoxy-2-methyl propionaldehyde
(1 time)
|
Environmental Health
(1 time)
|
AC (1 time)
AOP (1 time)
FA (1 time)
|
2001 MTBE oxidation by conventional ozonation and the combination ozone/hydrogen peroxide: efficiency of the processes and bromate formation.
|
| 73 |
3-mercaptomethylpropionate
(1 time)
|
Chemistry
(1 time)
|
MNIC (1 time)
|
2014 Transformation of a mononitrosyl iron complex to a [2Fe-2S] cluster by a cysteine analogue.
|
| 74 |
3-methyl-4-(methylthio)phenol
(1 time)
|
Environmental Health
(1 time)
|
hERalpha (1 time)
HPLC (1 time)
MMS (1 time)
|
2010 A novel estrogenic compound transformed from fenthion under UV-A irradiation.
|
| 75 |
3-O-methyl-D-mannose-containing polysaccharide
(1 time)
|
Biochemistry
(1 time)
|
SD-MMP (1 time)
|
1977 Heterogeneity and refined structtures of 3-O-methyl-D-mannose polysaccharides from Mycobacterium smegmatis.
|
| 76 |
actin-collagen-matrix metalloproteinases
(1 time)
|
Medicine
(1 time)
|
NHP (1 time)
|
2011 Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.
|
| 77 |
c-Myc, p53, Bax, Bcl-2, metalloproteinase
(1 time)
|
Medicine
(1 time)
|
MDM2 (1 time)
VEGF (1 time)
|
2016 [Effect and Regulatory Mechanism of Clock Gene Per1 on Biological Behaviors of Human Oral Squamous Carcinoma Cell].
|
| 78 |
Epac1-to-matrix metalloprotease
(1 time)
|
Neurology
(1 time)
|
Epac1 (1 time)
|
2013 Role of HIF-1alpha-activated Epac1 on HSC-mediated neuroplasticity in stroke model.
|
| 79 |
lysoPC-mediated proliferation could occur by stimulating metalloproteinase
(1 time)
|
Pharmacology
(1 time)
|
lysoPC (1 time)
oxLDL (1 time)
SMC (1 time)
|
2002 Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.
|
| 80 |
Macrophage membrane potential
(1 time)
|
Biology
(1 time)
|
---
|
1975 [Macrophage membrane potential test: an electrophysiological modification of the Field-Caspary test in melanoma patients].
|
| 81 |
macrophage membrane proteins
(1 time)
|
Medicine
(1 time)
|
CA (1 time)
Hc (1 time)
|
2003 Interaction of Histoplasma capsulatum yeasts with galactosylated surface molecules of murine macrophages.
|
| 82 |
magnetic mesoporous phenolic resin
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
PEI (1 time)
|
2018 In Situ Synthesis of Magnetic Mesoporous Phenolic Resin for the Selective Enrichment of Glycopeptides.
|
| 83 |
magnetic microparticles probe
(1 time)
|
Virology
(1 time)
|
CV (1 time)
GNPA (1 time)
HCV (1 time)
|
2017 An improved gold nanoparticle probe-based assay for HCV core antigen ultrasensitive detection.
|
| 84 |
magnetic mineral particles
(1 time)
|
Microbiology
(1 time)
|
RML (1 time)
XRD (1 time)
|
2009 Effect of oxidative stress on the growth of magnetic particles in Magnetospirillum magneticum.
|
| 85 |
mainly by inhibition of metalloproteinase
(1 time)
|
Medicine
(1 time)
|
Hh (1 time)
|
2013 Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo.
|
| 86 |
maintenance methadone programmes
(1 time)
|
Pulmonary Medicine
(1 time)
|
CI (1 time)
DOT (1 time)
HIV (1 time)
|
1998 Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners.
|
| 87 |
major mastitis pathogens
(1 time)
|
Microbiology
(1 time)
|
SCC (1 time)
|
1999 Preliminary studies on the prevalence of Mycoplasma bovis mastitis in dairy in cattle in Australia.
|
| 88 |
maleimidomethyl-3-maleimido propionate
(1 time)
|
Biochemistry
(1 time)
|
---
|
1981 Cross-linking of intact erythrocyte membrane with a newly synthesized cleavable bifunctional reagent.
|
| 89 |
Malignant melanoma of the penis
(1 time)
|
Dermatology
(1 time)
|
---
|
1990 A gray-brown discoloration of the penis. Malignant melanoma of the penis (MMP).
|
| 90 |
Malignant pleural mesothelioma
(1 time)
|
Medicine
(1 time)
|
---
|
2012 [Malignant pleural mesothelioma].
|
| 91 |
Mallampati classification
(1 time)
|
Anesthesiology
(1 time)
|
---
|
2014 Observational study of Mallampati changes after prone spinal surgery.
|
| 92 |
mandated medical program
(1 time)
|
Metabolism
(1 time)
|
---
|
2011 Insurance-mandated medical programs before bariatric surgery: do good things come to those who wait?
|
| 93 |
Many authors have described the role ofmatrixmetalloproteinases
(1 time)
|
General Surgery
(1 time)
|
ECM (1 time)
TIMPs (1 time)
|
2010 [The role of matrixmetalloproteinases in the tumor growth and metastasis].
|
| 94 |
marine mammal park
(1 time)
|
|
SWTD (1 time)
|
2018 Reassessing public opinion of captive cetacean attractions with a photo elicitation survey.
|
| 95 |
Marine Metagenomics Portal
(1 time)
|
Biochemistry
(1 time)
|
---
|
2018 The MAR databases: development and implementation of databases specific for marine metagenomics.
|
| 96 |
markers such as metalloprotease
(1 time)
|
Biochemistry
(1 time)
|
CA-LEF (1 time)
|
2005 Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification.
|
| 97 |
matched-mode processing
(1 time)
|
Audiology
(1 time)
|
RMMP (1 time)
|
2000 Regularized matched-mode processing for source localization.
|
| 98 |
matching pursuit algorithm
(1 time)
|
Biomedical Engineering
(1 time)
|
MEG (1 time)
|
2009 Single-trial evoked brain responses modeled by multivariate matching pursuit.
|
| 99 |
maternal malperfusion
(1 time)
|
Perinatology
(1 time)
|
---
|
2015 Placental hypoxia: the lesions of maternal malperfusion.
|
| 100 |
matrix metalloproteinases family members
(1 time)
|
Cell Biology
(1 time)
|
ceRNA (1 time)
TNBC (1 time)
|
2018 Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs.
|
A Search Service for Abbreviation / Long Form